qXR-CTR vs KardiaAI
AI Verdict
Choose qXR-CTR if…
Choose qXR-CTR if your radiology department or cardiology practice frequently utilizes chest X-rays for initial cardiac assessments. This tool is ideal for automating the measurement of the cardiothoracic ratio, providing a consistent and efficient way to screen for enlarged hearts and potential heart failure risk directly from imaging data.
View qXR-CTR →Choose KardiaAI if…
Choose KardiaAI if you require an FDA-cleared AI solution for analyzing ambulatory ECG rhythms to detect a wide range of cardiac conditions. This is best suited for integrating into mobile health applications or existing ECG devices, offering real-time, medical-grade detection of arrhythmias like AFib, bradycardia, and tachycardia for continuous patient monitoring.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | qXR-CTR | KardiaAI |
|---|---|---|
| Pricing | Unknown | Subscription-based for advanced features and services. |
| Deployment | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. | Mobile app, cloud-based. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
KardiaAIKardiaAI (Tool B) offers a more direct and accessible user experience through its integration into mobile apps and web platforms, making it suitable for both patients and healthcare professionals for on-demand ECG analysis. qXR-CTR (Tool A) is primarily an automation tool integrated into existing radiology workflows, which, while efficient for radiologists, has less direct user interaction.
Clinical Value
KardiaAIKardiaAI (Tool B) provides a broader range of diagnostic capabilities by detecting multiple cardiac conditions from ambulatory ECG rhythms, including AFib, bradycardia, and tachycardia. qXR-CTR (Tool A) focuses on a single, albeit important, metric (cardiothoracic ratio) from chest X-rays, primarily aiding in heart size assessment and heart failure risk.
Pricing & Value
KardiaAIKardiaAI (Tool B) offers transparent, publicly disclosed subscription-based pricing with clear tiers, allowing users to easily understand the cost and value proposition. qXR-CTR (Tool A) requires direct contact for pricing, which makes it less transparent and more challenging for potential customers to assess its value without engaging in a sales process.
Enterprise Readiness
qXR-CTRBoth tools are FDA-cleared, HIPAA compliant, and have BAAs, indicating strong regulatory readiness. However, qXR-CTR (Tool A) explicitly offers cloud, on-premise, and hybrid deployment options, providing greater flexibility for large enterprise healthcare systems with diverse infrastructure and data governance requirements. KardiaAI (Tool B) primarily functions as an SaMD and API library, which is also enterprise-ready but with a different deployment focus.
Innovation
KardiaAIKardiaAI (Tool B) demonstrates greater innovation through its deployment as an AI software library and API, enabling seamless integration into various mobile apps and web platforms for broad, accessible ECG analysis. This approach facilitates widespread patient monitoring and remote diagnostics. qXR-CTR (Tool A) automates a specific measurement within traditional imaging workflows, which, while valuable, represents a more incremental innovation.
Support & Docs
KardiaAIKardiaAI (Tool B) provides extensive and publicly accessible support resources, including detailed user manuals in multiple languages, FAQs, and direct contact information for support. While Qure.ai (Tool A) offers a user manual for its app and implied enterprise support, the breadth and public availability of support documentation appear more comprehensive for KardiaAI.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | qXR-CTR | KardiaAI |
|---|---|---|
| Name | qXR-CTR | KardiaAI |
| Company | Qure.ai Technologies | AliveCor |
| Primary Input / Function | Automates measurement of cardiothoracic ratio (CTR) from chest X-ray images. | AI software library for analyzing ambulatory ECG rhythms. |
| Key Analysis / Detections | Automated measurement of cardiothoracic ratio (CTR) for assessing heart size and potential heart failure risk. | Detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE), ECG noise filtering and noisy ECG detection. |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
Videos
Demos, reviews, and walkthroughs featuring qXR-CTR and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring qXR-CTR or KardiaAI
Backers
Who funded each tool's parent company.